Arrow Funds Adds Two ETFS to E*TRADE's Commission-Free ETF

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
168
Arrow Funds Adds Two ETFS to E*TRADE's Commission-Free ETF Platform

LAUREL, MD --(Marketwired - May 03, 2017) - Arrow Funds today placed two ArrowShares exchange-traded funds (ETFs) on E*TRADE's Commission-Free ETF platform. 1 The firm's flagship ETF, Arrow Dow Jones Global Yield ETF ( NYSE : GYLD ), as well as the Arrow DWA Tactical ETF ( NASDAQ : DWAT ) can now be bought and sold without paying brokerage commissions via E*TRADE's platform.

"We are pleased to enhance accessibility to two Arrow ETFs that can help investors meet specific portfolio needs," said Joseph Barrato, CEO and Director of Investment Strategy at Arrow Funds. "The Arrow Dow Jones Global Yield ETF addresses the income challenge that so many investors currently face, while the Arrow DWA Tactical ETF offers an attractive option for investors seeking a global macro strategy."

Benchmarked to the Dow Jones Global Composite Index℠, the Arrow Dow Jones Global Yield ETF (GYLD) provides global, multi-asset exposure to traditional and alternative sources of yield, including Global Sovereign Debt, Global Equity, Global Real Estate, Global Alternatives (Master Limited Partnerships) and Global Corporate Debt. GYLD is equally weighted across its five yield categories to reduce over-exposure to individual securities, as typically experienced by cap-weighted indexes. The ETF has a 30-Day SEC Yield of 6.69% and a Distribution Rate of 6.48% as of the latest distribution on April 17, 2017.

The Arrow DWA Tactical ETF (DWAT) , on the other hand, provides an active strategy that leverages the technical analysis expertise of Dorsey, Wright & Associates (DWA) to respond to changing market conditions. Based on the DWA Systematic Global Macro Model, DWAT allocates to those market segments demonstrating the strongest relative strength among Global Equities, Global Fixed Income and Global Alternatives such as real estate, currencies and commodities. DWAT's strict relative strength buy and sell discipline offers a sharp contrast to many other global macro strategies that rely primarily on subjective macroeconomic analysis with the risk of manager bias.

"As investors' level of sophistication grows, so does their interest and awareness of ETFs beyond the mainstream as they seek nuanced strategies that can be deployed for specific opportunities," said Rich Messina, SVP, Investment Product Management at E*TRADE. "With the addition of two Arrow ETFs, we continue in our pursuit to offer our customers a robust range of investment choices that are commission-free to trade."

In addition to GYLD and DWAT which are now available on E*TRADE's Commission-Free ETF platform, Arrow also offers the Arrow QVM Equity Factor ETF (QVM) and the Arrow Reserve Capital Management ETF (ARCM) and a full suite of mutual funds.

About Arrow: Arrow Funds, including the exchange traded product line ArrowShares, is a company that offers targeted portfolio solutions for ever-changing markets. The company's vision is to be recognized as the leading provider of alternative and tactical investment solutions with a focus on education, research and client service as the cornerstones. To learn more, visit www.ArrowFunds.com .

Before investing, please read the prospectus and shareholder reports to learn about the investment strategy and potential risks. Investing involves risks, including the potential for loss of principal. An investor should consider the fund's investment objective, charges, expenses and risks carefully before investing. This and other information about the fund is contained in the fund's prospectus, which can be obtained by calling 1-877-277-6933.

Arrow Dow Jones Global Yield ETF may not be suitable for all investors. The fund may not replicate the exact performance of the benchmark because of fees, expenses, trading costs and portfolio tracking error. Exchange traded products are bought and sold at market price, not NAV, and are not individually redeemed from the fund. Buying and selling shares generally results in brokerage commissions which will reduce returns. Fixed income securities may be subject to risks associated with interest rate fluctuations. International investments may involve additional risks, including, but not limited to, currency fluctuation, accounting methods, and geopolitical instability. Emerging markets involve heightened risks related to the same factors as well as increased volatility and potentially lower trading volume. Changes in laws, domestically or abroad, could result in the inability of the fund to operate as described in the prospectus. Narrowly focused investments may be subject to higher volatility. High yielding stocks and non-investment grade bonds are often higher risk investments which may be subject to greater volatility. Master Limited Partnerships (MLPs) and Royalty Investment Trusts (RITs) have specific risks, including, among others, limited voting rights, energy demand, limited call rights of the general partner, and tax law changes. In order to qualify for the tax treatment of a regulated investment company (RIC) the fund's exposure to MLPs can not exceed 25%, or may be subject to corporate taxes which would reduce performance. Investments in securities of real estate companies involves risks including, among others, adverse changes in real estate conditions domestically or abroad, availability or obsolescence of properties, cost and terms of mortgages, and changes of laws.

Arrow DWA Tactical ETF may not be suitable for all investors. Exchange traded products are bought and sold at market price, not NAV, and are not individually redeemed from the fund. Buying and selling shares generally results in brokerage commissions which will reduce returns. The market price may be higher (premium) or lower (discount) than the Net Asset Value (NAV). The fund may invest in commodity-related securities, which may be subject to greater volatility than investments in traditional securities. The fund may invest in international and emerging market securities, which may be subject to special risks including fluctuations in currency, government regulation, differences in accounting standards and liquidity. Investing in small-cap securities may have special risks, including wider variations in earnings and business prospects than larger, more established companies. The fund may invest in real estate-related securities, which may be subject to mortgage-related risks and real estate market fluctuations. The fund may invest in fixed income securities, which are subject to risks including interest rate, credit and inflation.

1. You can buy and sell the exchange-traded funds (ETFs) available through the E*TRADE Securities commission-free ETF program without paying brokerage commissions. For margin customers, ETFs purchased through the program are not margin eligible for 30 days from the purchase date. To discourage short-term trading, E*TRADE Securities may charge a short-term trading fee on sales of participating ETFs held for less than 30 days.

Content reviewed by an affiliate, Archer Distributors, LLC (member FINRA). AD-050317

Media Contacts: Lori Klash Winkler Lori@arrowfunds.com 619.743.2848 Chris Sullivan Chris@macmillancom.com 212.473.4442

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 425

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 86

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 268

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 323

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 15

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Webull Faces Class Action: Key Details for Investors

Updated Category News Views 340

What's Really Going on With Webull? When you hear there's a class-action lawsuit brewing, you know something's gone real sideways. Webull Corporation (NASDAQ: BULL) finds itself neck-deep in a securities fraud class action alleging some dicey dealings with China. If you've got skin in the game—and if you bought Webull stock between April 26, 2025, and October 6,...

Continue Reading

Top 5 Most Recently Viewed Articles

Laugh Factory's Annual Free Thanksgiving Feast Returns to Hollywood

Updated Category News Views 239

Laugh Factory's Holiday Tradition: A Thanksgiving Feast The world-renowned Laugh Factory in Hollywood proudly continues its cherished tradition by hosting the 45th consecutive annual free Thanksgiving feast. This Thanksgiving, the club opens its doors for four seatings at 1 p.m., 3 p.m., 5 p.m., and 7 p.m., offering an incredible opportunity for community members to come...

Continue Reading
Recognizing Thomas Edwards Jr.: A Champion of Justice

Updated Category News Views 275

Celebrating Excellence in Legal Advocacy Attorney Thomas S. Edwards, Jr., a Senior Partner at Edwards & Ragatz, P.A., has been honored with the prestigious "Compassionate Gladiator Award" by the Florida Justice Association (FJA). This esteemed award is presented to legal professionals who exhibit exceptional dedication to their clients and the legal system, reflecting the...

Continue Reading
Growth Journey of Plant-Based Dairy: Trends and Insights

Updated Category News Views 283

Exploring the Plant-Based Dairy Products Market The plant-based dairy products market is witnessing remarkable growth, driven by evolving consumer preferences and increasing awareness regarding health benefits and sustainability practices. Initially valued at USD 20 billion, market experts project it to reach USD 34 billion by 2030, fueled by a promising CAGR of 9%...

Continue Reading
Catch the Excitement of Monster Jam at Northern Tool + Equipment

Updated Category News Views 138

Monster Jam Hits Northern Tool + Equipment in Oklahoma City Northern Tool + Equipment is thrilled to announce an upcoming event that promises to be packed with excitement and entertainment for the community. This special day will spotlight a legendary Monster Jam truck, bringing the high-octane thrill of motorsports to local fans. Exclusive Offers for Customers As part of...

Continue Reading
Analyzing NVIDIA’s Competitive Edge in Semiconductor Sector

Updated Category News Views 214

Understanding NVIDIA's Role in the Semiconductor Industry In the fast-paced world of technology, evaluation of companies within specific sectors is vital for investors and enthusiasts. This article focuses on NVIDIA (NASDAQ: NVDA), a leader in the Semiconductors & Semiconductor Equipment industry, and compares its performance with key competitors. By analyzing crucial...

Continue Reading